Innovation1 Biotech Stock Five Year Return
| IVBT Stock | USD 0 0.00 0.00% |
Innovation1 Biotech fundamentals help investors to digest information that contributes to Innovation1 Biotech's financial success or failures. It also enables traders to predict the movement of Innovation1 OTC Stock. The fundamental analysis module provides a way to measure Innovation1 Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innovation1 Biotech otc stock.
Innovation1 |
Innovation1 Biotech OTC Stock Five Year Return Analysis
Innovation1 Biotech's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Innovation1 Biotech has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Innovation1 Fundamentals
| Return On Equity | -1.79 | |||
| Return On Asset | -0.0781 | |||
| Current Valuation | 1.83 M | |||
| Shares Outstanding | 20.02 M | |||
| Shares Owned By Insiders | 74.66 % | |||
| Price To Earning | 0.01 X | |||
| Price To Book | 0.05 X | |||
| Gross Profit | (17 K) | |||
| EBITDA | (38.33 M) | |||
| Net Income | (40.88 M) | |||
| Cash And Equivalents | 636.16 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 554.4 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | 0.10 X | |||
| Cash Flow From Operations | (3.13 M) | |||
| Earnings Per Share | 5.54 X | |||
| Beta | 5.08 | |||
| Market Capitalization | 4.5 M | |||
| Total Asset | 43.96 M | |||
| Z Score | 4.8 | |||
| Net Asset | 43.96 M |
About Innovation1 Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovation1 Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovation1 Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovation1 Biotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.